装逼备忘录2020-03-21 12:39
#新冠肺炎# 股票今日表现
$Biofrontera(BFRA)$ reduces staff
$Tonix医药控股(TNXP)$ +72%
$柏勒罗丰治疗(BLPH)$ +431%
详见: 网页链接查看全文
$Biofrontera(BFRA)$ 15F-12B Securities registration termination of foreign private issuers [Section 12(b)] Accession Number: 0001493152-22-006407 Act: 34 Size: 40 KB 网页链接
$Biofrontera(BFRA)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001493152-22-006381 Act: 33 Size: 49 KB 网页链接
$Biofrontera(BFRA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001493152-22-006377 Act: 33 Size: 55 KB 网页链接
$Biofrontera(BFRA)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001213900-22-009463 Act: 34 Size: 532 KB 网页链接
$Biofrontera(BFRA)$ 25 Notification of the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001493152-22-005390 Act: 34 Size: 17 KB 网页链接
$Biofrontera(BFRA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-22-005379 Act: 34 Size: 74 KB 网页链接
$Biofrontera(BFRA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-22-005070 Act: 34 Size: 39 KB 网页链接
$Biofrontera(BFRA)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001493152-22-003744 Size: 87 KB 网页链接
$Biofrontera(BFRA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-22-002842 Act: 34 Size: 36 KB 网页链接
$Biofrontera(BFRA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-22-001110 Act: 34 Size: 36 KB 网页链接